Dr. Leila Sofia Bolandgray, MD

Dr. Bolandgray practices at Sharp Coronado Hospital in Coronado, California, part of Sharp HealthCare.

Dr. Bolandgray's NPI, 1093931727, was assigned on April 18, 2007. Dr. Bolandgray graduated from St. George's University School of Medicine in 1997. Dr. Bolandgray holds California license A72176.

Dr. Bolandgray's primary practice is Sharp Coronado Hospital, at 250 Prospect Place, Coronado, CA 92118 in San Diego County. The practice phone is (619) 435-6251.

Dr. Bolandgray's primary practice is Sharp Coronado Hospital in Coronado, California, part of Sharp HealthCare. Dr. Bolandgray is also affiliated with Sharp Grossmont Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Bolandgray to 1 more physician office, 1 hospice, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bolandgray practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bolandgray's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bolandgray is board certified in internal medicine by the American Board of Internal Medicine. Dr. Bolandgray is licensed in California.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, cardiac arrhythmia, cellulitis, chronic hypertension, chronic obstructive pulmonary disease (COPD) and collapsed lung among the conditions Dr. Bolandgray treats.

CMS data shows 942 Medicare services from Dr. Bolandgray across 7 procedure codes in 2024, for 253 Medicare patients. Medicare paid $88,411 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 253 Medicare patients who saw Dr. Bolandgray in 2024. The largest group is 75 to 84, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bolandgray's median patient age at 76, with 55% women.

In 2024, Dr. Bolandgray wrote 3,111 Medicare Part D claims for 335 patients. 86% of them were for generic drugs. CMS names the drug for 2,496 of them, across 79 drugs with 11 or more claims each, at $112,440 in total drug cost. In 2023, CMS named 1,856 claims across 63 drugs.

Dr. Bolandgray accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 70 general payments to Dr. Bolandgray from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $754.

Dr. Bolandgray graduated from St. George's University School of Medicine in 1997.

Dr. Bolandgray is in network with 2 carriers, including Molina and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.